chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: SMALL
Symptoms: Red blood cell sedimentation rate increased, Troponin I increased
Clinical narrative: The pt received his primary SPV in the left upper arm on 5/22/12. He was in his normal state of good health at the time. About 2 days later he noticed that he was fatigued. On day 3 he noted generalize muscle aches and axillary and cervical lymphadenopathy. On day 7 he felt feverish and chilled-he did not seek medical attention nor did he miss any work days. Additionally, on 5/29/12 (day 7) he noted a 2 minute episode of left sided dull, non-radiating, chest pain (2/10) while at rest. The pt denied N, V, SOB or diaphoresis. He thought that might have "heartburn" as he had eaten fried food for dinner (the pt denies prior hx of "heartburn"). The symptoms resolved without treatment. The pt experienced a second episode of substernal chest pain (4/10) while resting on 6/2/12. The pain lasted about 10 minutes and radiated from the sternum to the anterior chest. It resolved without treatment. He denied any other symptoms (N, V, diaphoresis, SOB). On 6/11/12 around 10 am while at work he noted 10/10 severe substernal chest "pressure" which improved leaning forward and worsened with leaning back. He was diaphoretic and nauseated (he denied V, SOB, or palpitations). The pt stated that the pain radiated to both arms intermittently. The pt reported to the ER. He had a normal PE (no murmur, no chest tenderness). He was given MOTRIN at 1100 with improvement of his chest pain (5/10) after about 90 minutes. The EKG showed NSR with early repolarization. CSR results are below. He was diagnosed with pericarditis and he was started on NAPROSYN 500 mg bid. He was seen in Cardiology Clinic on 6/18/12 where he reported that he continues to experience substernal chest pressure which lasts about 2 minutes and occurs about 2 minutes and occurs about 3 time per day (unrelated to activity). He had an EKG which showed NSR and a normal ECHO. He was diagnosed with atypical chest pain; instructed to continue NAPROSYN bid for 2 more weeks; stress echo will be considered if pain continues or worsens.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Local reaction
Clinical narrative: Intense local reaction at injection site.
Age: 18.0
Sex: M
Vaccine: MEN
Symptoms: Convulsion, Dizziness, Loss of consciousness, Pyrexia
Clinical narrative: Momentary loss of consciousness followed by seizure. After two hours of rest, symptoms including dizziness and fever remained.
Age: 22.0
Sex: F
Vaccine: PPV
Symptoms: Culture negative, Injection site erythema, Injection site induration, Injection site pain, Pain in extremity
Clinical narrative: PT C/O OF PAIN AT INJECTION SITE AND GENERALIZED PAIN OF R ARM. DEVELOPED FEVER TO 103F, SITE BECAME RED AND APPROX 10CM OF INDURATION TRANSFERRED TO ED AND ADMITTED FOR TREATMENT WITH ORAL ABX, CULTURES NEGATIVE.
Age: 22.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: PT C/O OF PAIN AT INJECTION SITE AND GENERALIZED PAIN OF R ARM. DEVELOPED FEVER TO 103F, SITE BECAME RED AND APPROX 10CM OF INDURATION TRANSFERRED TO ED AND ADMITTED FOR TREATMENT WITH ORAL ABX, CULTURES NEGATIVE.
Age: 18.0
Sex: F
Vaccine: MEN
Symptoms: Convulsion, Dizziness, Loss of consciousness, Vomiting
Clinical narrative: Momentary loss of consciousness followed by seizure. After two hours of rest, symptoms including dizziness and vomiting remain.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: C/O OF PAIN IN THE ARM WHERE HE RECEIVED THE INJECTION.
Age: 6.0
Sex: M
Vaccine: DTAP
Symptoms: Hypersomnia, Pyrexia, Somnolence, Vomiting
Clinical narrative: 11pm throwing up and fever (101.8) all thru the night. The next day fever was gone by about 9am and vomiting done. He slept the entire day only waking twice for a small snack. He was difficult to wake and slept thru bathing and dressing. Continued sleeping until 9am the next morning 6/17/2012
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Blood thyroid stimulating hormone, Dizziness, Full blood count, Metabolic function test, Mononucleosis heterophile test
Clinical narrative: Sore throat, vomiting, dizziness see attached note.
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Oropharyngeal pain, Vomiting
Clinical narrative: Sore throat, vomiting, dizziness see attached note.
Age: 11.0
Sex: M
Vaccine: HPV4, MEN, TDAP, HPV4, MNQ, TDAP
Symptoms: Erythema, Injection site urticaria, Oedema peripheral, Urticaria
Clinical narrative: HIVES ON HIS LEGS, ABDOMEN, AND ON RT DELTOID WHERE VACCINE WAS ADMINISTERED. HAS REDNESS & SWELLING ON RT ARM.
Age: 44.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Rash to trunk; has persisted from 05/11/12 through today's date; 06/22/2012.  Itchy, red rash over trunk.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Body temperature increased, Dizziness, Injection site pain, Malaise
Clinical narrative: Dizzy, malaise, temp 102.2, injection sites painful.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: Per mom warmth and swelling. 2 days after MENACTRA vaccination. Denies fever. Today decreased swelling and erythema.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site induration, Injection site warmth
Clinical narrative: Injection site induration, large area, got to touch.
Age: 48.0
Sex: F
Vaccine: TDAP
Symptoms: Paraesthesia oral, Speech disorder
Clinical narrative: Pt c/o inability to speak with lips tingling 30-35 minutes after receiving Tdap vaccine. Inability to speak lasted a few seconds.
Sex: U
Vaccine: FLUX
Symptoms: Congenital anomaly, Foetal exposure during pregnancy, Limb reduction defect
Clinical narrative: Case number PHHY2012US051529 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse event (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051523). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with upper limb reduction defect. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Age: 16.0
Sex: M
Vaccine: TDAP, YF
Symptoms: Rash
Clinical narrative: Rash.
Sex: U
Vaccine: FLUX
Symptoms: Congenital cystic lung, Foetal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051568 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051559). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with birth defect, cystic adenomatoid malformation. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no usual patterns of pregnancy complications or fetal outcome were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Biopsy, Blister, Body temperature, Headache, Pruritus
Clinical narrative: Severe itching, large blisters all over body, temperature, headache. Saw dermatologist (2) bi ops to rule out mites, prednisone, permethrin cream 5% and fluocinonide 0.05% cream.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Patient noticed a golf ball size rash around the injection site. She did not feel "funny" or SOB. She did not describe feeling abnormal. Followed up with patient 48 hours later and rash has not resolved. She did not seek any additional medical attention.
Sex: F
Vaccine: FLU3
Symptoms: Maternal exposure during pregnancy, Menorrhagia
Clinical narrative: Case number PHHY2012US051486 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unknown date after vaccination, the patient experienced menorrhagia. The outcome of the event menorrhagia and outcome of pregnancy were not known. The causality was not reported. The VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA vaccine.
Sex: U
Vaccine: FLU3
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051539 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA vaccine form 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051535). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with multiple deformities. The baby had multicystic renal dysplasia, atrial and ventricular septal defect and single umbilical artery. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
Sex: U
Vaccine: FLUX
Symptoms: Congenital central nervous system anomaly, Foetal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051553 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051547). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with birth defect, agenesis of the corpus callosum. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Foetal death, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051498 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unknown date after vaccination, the patient had intrauterine fetal death. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among present women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Gestational hypertension, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051496 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unknown date after vaccination, the patient developed pregnancy induced hypertension. The outcome of the event pregnancy induced hypertension and outcome of pregnancy were not known. The causality was not reported. The VAERS system does not allow for active follow-up of adverse events among present women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Maternal exposure during pregnancy, Placenta praevia
Clinical narrative: Case number PHHY2012US051492 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 from 30 Jun 2009. On an unknown date after vaccination, the patient had a complication of placenta previa. The outcome of the event placenta previa and outcome of pregnancy were not known. The causality was not reported. The VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Gestational diabetes, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051419 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unknown date after vaccination, the patient developed gestational diabetes. The outcome of the event gestational diabetes and outcome of pregnancy were not known. The causality was not reported. The VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent influenza vaccine.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Paraesthesia
Clinical narrative: Pt. called after leaving office pt. has paresthesias per Dr., no motor deficiency. Pt. mom was instructed to take pt. to hospital if symptoms worsen. Paresthesias occurred on (L) side of face.
Age: 22.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Local swelling
Clinical narrative: Symptoms: And local swelling and erythema. Treatment. Cephalexin 500 mg TID.
Age: 1.06
Sex: F
Vaccine: VARCEL
Symptoms: Blister, CSF test abnormal, Herpes zoster, Immunology test normal, Meningitis
Clinical narrative: Facial nerve zoster & meningitis (70 WBC) facial vesicles & CSF (+) PCR VZV -> sent to CDC, confirmed OKA strain. Limited immune evaluation normal.
Age: 1.06
Sex: F
Vaccine: VARCEL
Symptoms: Polymerase chain reaction, Varicella virus test positive, White blood cell count increased
Clinical narrative: Facial nerve zoster & meningitis (70 WBC) facial vesicles & CSF (+) PCR VZV -> sent to CDC, confirmed OKA strain. Limited immune evaluation normal.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Abdominal pain upper, Back pain, Body temperature increased, Chills, Nausea
Clinical narrative: Patient woke up at 3:00 am on 6/21/12 complaining of (Rt) arm pain, back pain, stomach pain, nausea, chills. Temp at 100.5 F. Reported by father at 1:15 - 6/21/12. Denied swelling, redness or rash at injection site. Advise to see private physician, seen at 3:30 pm at dr's office with redness, swelling at (Rt) arm, shoulder. Lab indicated UTI. Tx with ATB, PHENERGAN. Pt doing better as of 6-22-12 at 10:00 am.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Pain in extremity, Urinary tract infection
Clinical narrative: Patient woke up at 3:00 am on 6/21/12 complaining of (Rt) arm pain, back pain, stomach pain, nausea, chills. Temp at 100.5 F. Reported by father at 1:15 - 6/21/12. Denied swelling, redness or rash at injection site. Advise to see private physician, seen at 3:30 pm at dr's office with redness, swelling at (Rt) arm, shoulder. Lab indicated UTI. Tx with ATB, PHENERGAN. Pt doing better as of 6-22-12 at 10:00 am.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Malaise, Nausea
Clinical narrative: Patient felt extremely ill the day after receiving the shot. Her main complaint is nausea. This resolved after a few days, but patient did visit her physician.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Nausea, Pyrexia
Clinical narrative: Vaccine administered 6-20-12. Pt returned to clinic 6/22/12 complained of nausea, vomiting. Swelling and redness at injection site. Fever 101.2. Cellulitis (L) arm. Patient given Clindamycin 300mg one p.o TID x 7 days.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Vomiting
Clinical narrative: Vaccine administered 6-20-12. Pt returned to clinic 6/22/12 complained of nausea, vomiting. Swelling and redness at injection site. Fever 101.2. Cellulitis (L) arm. Patient given Clindamycin 300mg one p.o TID x 7 days.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling face
Clinical narrative: Patient had swelling on her face and was given antihistamine.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Headache, Oedema peripheral, Skin warm, Tenderness
Clinical narrative: Start with a headache on Wednesday evening.6/21/12-Very bad headache all day and night. 6/22/12 woke up with swollen, hot, red, tender arm, later, headache returned. 6/23/12 still have headache.
Age: 18.0
Sex: F
Vaccine: HPVX, MEN
Symptoms: Asthenia, Chills, Dizziness, Nausea, Pyrexia
Clinical narrative: Fever, chills, weakness, dizziness, nauseous.
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Flank pain, Pain, Urticaria
Clinical narrative: Severe pain in right side then the break out occurred with welts and blisters on that side, the break out occurred 1 1/2 days after the severe pain.
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Severe pain in right side then the break out occurred with welts and blisters on that side, the break out occurred 1 1/2 days after the severe pain.
Age: 78.0
Sex: F
Vaccine: PPV
Symptoms: Muscle swelling, Myosclerosis, Pain in extremity, Pruritus, Skin warm
Clinical narrative: Entire deltoid muscle swollen and firm, warm to touch.  Not red though.  Patient reports it is itchy, and a little painful.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Patients right is swollen about 3 inches in diameter at the site of injection. Erythema is present as well as pruritus and patient states it feels warm. Said she put ice on it yesterday.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Constipation, Diarrhoea, Pyrexia, Retching
Clinical narrative: Constipation on Wed 6/20. Dry heaves, some diarrhea, unknown fever began Friday and Saturday. No problems on Sunday 6/24 (spoke to pt 1 pm).
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt. got the vaccine on Tuesday June 19, 2012. On Friday 6/22/12 the patient called to inform us that her arm had become red, hot and swollen surrounding the injection site in the days following her vaccination.
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic, Vaccination complication
Clinical narrative: Patient said she had a reaction to shingles vaccine - itchy rash from her neck to her head. Dermatologist treated her with shingle meds: VALTREX and Gabapentin.
Age: 12.0
Sex: M
Vaccine: DTAP, MEN
Symptoms: Chills, Muscle spasms, Pyrexia
Clinical narrative: Sudden onset of high fever 103.2 degrees Fahrenheit muscle cramps- continued fever no other symptoms besides severe chills not relieved by Advil.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site streaking, Injection site warmth, Oedema peripheral, Pyrexia
Clinical narrative: Extreme swelling in arm.  Red streaks leading downward from where the injection site was.  Arm twice the size of the unvaccinated arm.  Fever of 100.  Injection site very hot to the touch.
Age: 41.0
Sex: M
Vaccine: TDAP
Symptoms: Axillary pain, Hypoaesthesia, Injection site erythema, Injection site warmth, Pain
Clinical narrative: Tdap injection given on 6/18, area approx 2" around injection site hot to touch raised red, numbness and tingling down to fingers, throbbing pain in armpit. Symptoms still persist 6 days after injection.
Age: 41.0
Sex: M
Vaccine: TDAP
Symptoms: Paraesthesia
Clinical narrative: Tdap injection given on 6/18, area approx 2" around injection site hot to touch raised red, numbness and tingling down to fingers, throbbing pain in armpit. Symptoms still persist 6 days after injection.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Patient waited in office for 20 minutes after administration of her Hep A #2 and HPV #3 vaccines without reaction. She returned to clinic later in day stating that approximately 20 minutes after she left, she developed hives on her neck, shoulder, and arms. She applied an OTC anti itch cream at home since the lesions were pruritic and got some relief. One lesion on her elbow fully resolved. She denied shortness of breath, cough, nausea, vomiting, or swelling of face/lips/tongue/throat. On exam, she was alert in no acute distress and her exam was notable for 6 isoated wheals (hives) - 2 on R forearm, 2 on R side of neck, 1 on R shoulder, 1 on L upper arm. HEENT/CV/RESP exams were normal. She was advised to use 1% hydrocortisone cream for itch and OTC Zyrtec 10 mg po once daily for itch/hives, and to seek care in ER ASAP if symptoms worsening or developed shortness of breath, swelling, or vomiting. I conducted phone follow up with patient/mother on 6-19-2012 and patient was doing well. Only developed 2 new hives since I saw her. No other new symptoms occurred. We have referred patient to local allergist for furthet evaluation.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Nasal congestion, Pain, Swelling
Clinical narrative: An oval area about 2 by 4 inches became bright red, swollen and painful and nasal congestion.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Apnoea, Bradycardia, Sleep study normal
Clinical narrative: Premature infant on 1/2L NC O2 since 6/17/12. Off caffeine since 6/11/12. 2 month immunizations ordered. On 6/22/12 DTAP-Hepatitis B-IPV (PEDIARIX) given on 6/22/12 at 1750. On 6/23/12 (ACTHIB) & PREVNAR-13 given at 1225. Infant started to have bradycardic event at 1433 then apnea & bradycardic events at 1704, 1804, 1854, 2215, & 0120 that required tactile stimulation. Sleep study ordered. No apnea & bradycardic events since.
Age: 1.05
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Balance disorder, Cerebellar ataxia, Computerised tomogram head, Fall
Clinical narrative: Pt became off balance with walking - falling over - had been walking approximately 1 mth. Mom convinced child acted drunk - fell & wobbly for few days - felt regressed - saw Dr. - Dx with cerebellum ataxia cerebellar ataxia.
Age: 13.0
Sex: M
Vaccine: HEPA
Symptoms: Cardiac arrest
Clinical narrative: Patient suffered cardiac arrest episode.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Patient had ZOSTAVAX injection Friday 6/22/12 called morning Monday June 25th with report of chicken pox like rash on arms and legs with no fever.
Sex: U
Vaccine: PPV
Symptoms: Erythema, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with a dose of PNEUMOVAX 23 (lot # 665300/1314Y) within the month of April 2010 from the same 5 dose vial. On unspecified date, the patient experienced very large redness wrapping around the arm and warmth/feverish at the injection site. The patient was treated with oral BENADRYL and ice and recovered. This is one of several reports received from the same source. The nurse is requesting a lot check. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
Sex: U
Vaccine: PPV
Symptoms: Erythema, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with a dose of PNEUMOVAX 23 (lot # 665300/1314Y) within the month of April 2010 from the same 5 dose vial. On unspecified date, the patient experienced very large redness wrapping around the arm and warmth/feverish at the injection site. The patient was treated with BENADRYL and ice and recovered. This is one of several reports received from the same source. The nurse is requesting a lot check. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
Age: 23.0
Sex: M
Vaccine: TYP
Symptoms: Initial insomnia, Oral disorder, Oral pain, Papule, Pruritus
Clinical narrative: 23 y/o m referred to clinic by another clinic at 11 AM on 21MAY12. Patient received AVA #1, primary SPV and Typhoid Vi on 15MAY12. Patients presents to clinic with 3-day h/o of isolated sore inside left cheek (buccal mucosa) & under tongue at base of 2nd pre-molar on left. Oral lesions are sensitive ("sting") when in contact with warm liquids, citrus/spicy foods, toothpaste, etc. Patient also has a fine, isolated, pruritic, papulo-pustular lesion behind his right & left knees. which appeared yesterday (day # 5 s/p vaccines), as well as a fine, isolated, pruritic, papulo-pustular lesion on the tibial aspect of his rt lower extremity and one of the medial aspect of his left lower extremity, just above his ankle, which both appeared this morning (day #6 s/p vaccines). Patient states that these four fine, isolated, papulo-pustular lesions behind his knees and on his lower extremities are extremely pruritic. He had difficulty falling asleep last night secondary to the intense itching. These fine, pruritic, papulo-pustular lesions are follicular in appearance and appear to be consistent with Non-Viral Pustulosis (NVP) lesions s/p receipt of SPV. The patient denies any systemic malaise, fever, chills, HA, muscle ache, body ache, chest pain, pressure in center of chest or pleuritic SOB. His Jennerian pustule on his (rt) deltoid is consistent with evolution for Day #6 x/p SPV, w/o any significant erythema, warmth, streaking (lymphangitis) or axillary LAD. The patient is currently afebrile (98.9F), his BP is  113/72, HR is 70 regular and RR is 16. In NAD. Endorses moderate pain of "5"/10 localized in mouth upon ingesting warm liquids, citrus or spicy foods or with use of toothpaste. Patient denies HA, myalgias or arthralgias s/p receipt of vaccines. Endorses allergy to PCN. No food, shellfish or tree nut allergies. No allergies to latex or Neomycin. PMH is significant for h/o boils on lower extremities after bathing with soap. No recent change in soaps, detergents or shampoos. Patient denies a personal h/o eczema, atopic dermatitis, asthma, hay fever or psoriasis. He denies any chronic or autoimmune disease. Hosp/surg hx; Rt knee arthroscopy 2009. MEDS: ALEVER prn knee pain. Social hx: 23 y/o male with 2 (boys) ages 1 and 3 yrs. No smoking; No ETOH; No illicit drugs. IT Tech. Currently on work x 6 months. Start date: 28DEC05 (6 yrs). Family hx: M-55, living-fibromyalgia, cervical dysplagia/malignancy; Father - deceased at 50 yrs of age in log truck accident; Brother deceased at 19 yrs - shot. No first degree relatives to patient's knowledge with h/o eczema, atopic dermatitis, asthma or psoriasis. Knowledge with h/o eczema, atopic dermatitis, asthma or psoriasis.
Age: 23.0
Sex: M
Vaccine: TYP
Symptoms: Rash pustular, Skin lesion, Stomatitis
Clinical narrative: 23 y/o m referred to clinic by another clinic at 11 AM on 21MAY12. Patient received AVA #1, primary SPV and Typhoid Vi on 15MAY12. Patients presents to clinic with 3-day h/o of isolated sore inside left cheek (buccal mucosa) & under tongue at base of 2nd pre-molar on left. Oral lesions are sensitive ("sting") when in contact with warm liquids, citrus/spicy foods, toothpaste, etc. Patient also has a fine, isolated, pruritic, papulo-pustular lesion behind his right & left knees. which appeared yesterday (day # 5 s/p vaccines), as well as a fine, isolated, pruritic, papulo-pustular lesion on the tibial aspect of his rt lower extremity and one of the medial aspect of his left lower extremity, just above his ankle, which both appeared this morning (day #6 s/p vaccines). Patient states that these four fine, isolated, papulo-pustular lesions behind his knees and on his lower extremities are extremely pruritic. He had difficulty falling asleep last night secondary to the intense itching. These fine, pruritic, papulo-pustular lesions are follicular in appearance and appear to be consistent with Non-Viral Pustulosis (NVP) lesions s/p receipt of SPV. The patient denies any systemic malaise, fever, chills, HA, muscle ache, body ache, chest pain, pressure in center of chest or pleuritic SOB. His Jennerian pustule on his (rt) deltoid is consistent with evolution for Day #6 x/p SPV, w/o any significant erythema, warmth, streaking (lymphangitis) or axillary LAD. The patient is currently afebrile (98.9F), his BP is  113/72, HR is 70 regular and RR is 16. In NAD. Endorses moderate pain of "5"/10 localized in mouth upon ingesting warm liquids, citrus or spicy foods or with use of toothpaste. Patient denies HA, myalgias or arthralgias s/p receipt of vaccines. Endorses allergy to PCN. No food, shellfish or tree nut allergies. No allergies to latex or Neomycin. PMH is significant for h/o boils on lower extremities after bathing with soap. No recent change in soaps, detergents or shampoos. Patient denies a personal h/o eczema, atopic dermatitis, asthma, hay fever or psoriasis. He denies any chronic or autoimmune disease. Hosp/surg hx; Rt knee arthroscopy 2009. MEDS: ALEVER prn knee pain. Social hx: 23 y/o male with 2 (boys) ages 1 and 3 yrs. No smoking; No ETOH; No illicit drugs. IT Tech. Currently on work x 6 months. Start date: 28DEC05 (6 yrs). Family hx: M-55, living-fibromyalgia, cervical dysplagia/malignancy; Father - deceased at 50 yrs of age in log truck accident; Brother deceased at 19 yrs - shot. No first degree relatives to patient's knowledge with h/o eczema, atopic dermatitis, asthma or psoriasis. Knowledge with h/o eczema, atopic dermatitis, asthma or psoriasis.
Age: 22.0
Sex: F
Vaccine: ANTH, SMALL, TYP
Symptoms: Eczema, Folliculitis, Injection site urticaria, Skin lesion, Skin test
Clinical narrative: Received 3 doses of AVA between 24 Mar 08-21 Apr 08. She was evaluated on 11 Nov 08 for folliculitis x 2 mos on her legs. Lesions persisted and she was assessed as having eczematoid dermatitis. She was evaluated by dermatology in Feb 09 and underwent patch testing where it noted that she had redness and induration at formaldehyde, and redness and vesicles at quaternium-15. Derm follow up in June 09 reported that she was doing well with no lesions since May. In Oct 09 she received AVA #4 she reported that she developed a large urticarial rash on the arm where she received AVA without systemic symptoms and dev a skin flare in March 2010.
Sex: F
Vaccine: TYP
Symptoms: Oropharyngeal spasm, Throat tightness
Clinical narrative: Initial report was received from a healthcare professional on 15 June 2012. A female patient (age and birth date not reported) received an injection of TYPHIM VI, Sanofi Pasteur SA, lot number G0181-1 (route and site not reported) on 08 June 2012. On 10 June 2012 (reported as 11 June 2012 when patient required a doctor visit with her healthcare provider), patient developed tightness in throat and spasm of throat area which would come and go every few seconds, reported as 24 hours of symptoms at doctor visit on 11 June 2012. The patient reported symptoms resolved for the next 36 hours after doctor visit, then symptoms returned and still persisted on 15 June 2012, the date of report. The patient's medical history was not reported. The patient's outcome remained not recovered at time of report. Documents held by sender: None.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Allergy test negative, Blister, Body temperature increased, Computerised tomogram normal, Erythema
Clinical narrative: (Low temp). Left arm swelled size of baseball, hot & red. Severe headache, pain up left side of face & up & over left eye which swelled & pained. Broke out in blisters & itched. I am left with red "dots" across brow that itch daily now. I also suffered with severe sinus inflammation for months.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Eye pain, Face and mouth X-ray normal, Facial pain, Headache, Oedema peripheral
Clinical narrative: (Low temp). Left arm swelled size of baseball, hot & red. Severe headache, pain up left side of face & up & over left eye which swelled & pained. Broke out in blisters & itched. I am left with red "dots" across brow that itch daily now. I also suffered with severe sinus inflammation for months.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash pruritic, Sinusitis, Skin warm, Swelling face
Clinical narrative: (Low temp). Left arm swelled size of baseball, hot & red. Severe headache, pain up left side of face & up & over left eye which swelled & pained. Broke out in blisters & itched. I am left with red "dots" across brow that itch daily now. I also suffered with severe sinus inflammation for months.
Age: 50.0
Sex: F
Vaccine: TD, TDAP, TDAP
Symptoms: Diarrhoea, Emotional disorder, Mobility decreased, Pain in extremity, Vomiting
Clinical narrative: Severe pain of upper arm that over a period of 24 hours had move to the shoulder and elbow area.  Unable to move arm.  Vomiting, diarrhea.  Used Hydrocodone for pain.  Aleve and Tylenol didn't help a bit.  Using Hydrocodone only helped slightly with the pain.  I was in absolute agony.
Age: 50.0
Sex: F
Vaccine: TD, TDAP, TDAP
Symptoms: Neuralgic amyotrophy, Pain in extremity
Clinical narrative: Severe pain of upper arm that over a period of 24 hours had move to the shoulder and elbow area.  Unable to move arm.  Vomiting, diarrhea.  Used Hydrocodone for pain.  Aleve and Tylenol didn't help a bit.  Using Hydrocodone only helped slightly with the pain.  I was in absolute agony.
Age: 1.13
Sex: F
Vaccine: HEPA, MMRV, PER
Symptoms: Blister, Erythema, Rash
Clinical narrative: 4-5 raised red patches with clusters of blisters on extremities. They appeared similar to severe patches of eczema, except that the bumps appeared to be small blisters. I administered over the counter eczema cream. Following day, very small blisters were all over, the raised patches with clusters were more pronounced. Small individual blisters were covering the backs of her legs and feet. There were one or two on her fingers. Her torso and arms had very tiny bumps not quite blistering similar to mild case of eczema. Treated with warm bath and Benadryl. Doctor was called and reported he said to bring her in Monday which would be the following day. By the third day all the blisters appeared to be healing. No blisters were ever torn open and she did not appear too bothered by the blisters other than a little rubbing at her feet, which were covered in the tiny bumps.
Age: 0.63
Sex: M
Vaccine: DTAPHEPBIP, PNC
Symptoms: Convulsion
Clinical narrative: 5 seizures which continued, even while on Keppra, until a higher dose was given.
Age: 19.0
Sex: M
Vaccine: FLUX
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Dizziness, mild nausea, fatigue 8 PM. Home to bed 11 PM with body aches, fatigue, some nausea, possible fever. 06/23/2012 10 AM fever 100 degrees, extreme headache, no appetite, slept all day, nibbled at only one bowl of cold cereal. 06/24/2012 Headache receding, fever receing, extreme exhaustion, no appetite until mid-afternoon, ate some spaghetti and meatballs around 5 PM but didn't finish meal (a rare event for this young man). 06/25/12 achy all over (maybe from laying around for two days), still too tired to get up and walk around.
Age: 19.0
Sex: M
Vaccine: FLUX
Symptoms: Pain, Pyrexia, Somnolence
Clinical narrative: Dizziness, mild nausea, fatigue 8 PM. Home to bed 11 PM with body aches, fatigue, some nausea, possible fever. 06/23/2012 10 AM fever 100 degrees, extreme headache, no appetite, slept all day, nibbled at only one bowl of cold cereal. 06/24/2012 Headache receding, fever receing, extreme exhaustion, no appetite until mid-afternoon, ate some spaghetti and meatballs around 5 PM but didn't finish meal (a rare event for this young man). 06/25/12 achy all over (maybe from laying around for two days), still too tired to get up and walk around.
Age: 15.0
Sex: M
Vaccine: HPV4
Symptoms: Condition aggravated, Migraine, Partial seizures
Clinical narrative: Information has been received from a consumer concerning her 15 year old son with no drug reactions/allergies and a history of migraine who on approximately 15-MAY-2012 was vaccinated with his first dose of GARDASIL (Lot# and route not reported). There was no concomitant medication. Consumer reported that approximately 10 days following the vaccination her son experienced migraine with a partial onset seizure. Consumer reported that while her son had a history of migraines, he had never experienced a partial onset seizure before. The patient did not seek medical attention. Subsequently, the patient recovered from migraine and partial onset seizure on an unknown date. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site pain
Clinical narrative: Patient got shot on 6/14/12. On 6/16 pt reported lemon sized lump and hurt at injection site. She got scripts for Doxycycline and ibuprofen on 6/17.
Sex: U
Vaccine: FLU3
Symptoms: Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Case number PHHY2012US051907 is an initial literature report received on 12 Jun 2012, Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051905). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born. The baby developed jaundice on an unspecified date. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA vaccine.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site swelling, Local reaction
Clinical narrative: Local swelling on left arm where Dtap was given IM.
Age: 49.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site vesicles, Lymphadenopathy, Tenderness
Clinical narrative: 4.5 x 1.5 inch area of erythema, tenderness at injection site 48 hrs post injection. (L) axillary lymphadenopathy (< 1 cm), tender. 3.5 x 1.0 inch area of small developing vesicles within larger area of erythema.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Induration, Infection, Oedema peripheral, Rash, Swelling
Clinical narrative: Pt received vax 6/20/12. She presented at the pharmacy on 6/21/12 with rash, induration, & swelling. She was counseled on vaccination reaction & encouraged to see physician if she was concerned. Patient presented diagnosis of "infection" on 6/22/12 with cephalexin rx. Pt's rash had spread over 24 hours,but arm was less swollen.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Hypoaesthesia, Pain, Sleep disorder
Clinical narrative: Pain upon extension (up, out and especially behind) of left arm. Pain is often severe and interferes with sleep. Dressing and turning steering wheel are painful. Also experience frequent numbness from shoulder to fingertips.
Sex: F
Vaccine: FLU3
Symptoms: Asthma, Condition aggravated, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051978 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She had a history of asthma. She was vaccinated with influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination, her asthma got exacerbated. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of influenza vaccine.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Headache, Oedema peripheral, Pain in extremity
Clinical narrative: Headache, severe pain & swelling in arm (that was injected) treated with NSAIDS, chills.
Age: 0.56
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Injection site rash, Irritability, Pyrexia, Rash, Screaming
Clinical narrative: Elevated fever > 103. Very irritable. Screaming. Cranky. - Spots on leg & back.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Diarrhoea, Influenza like illness, Injection site pruritus, Injection site swelling
Clinical narrative: Diarrhea, joint pain, sleepy, flu like, low grade fever on 6/19/12 then 6/19 6:00pm or so, hives/rash begining at nap, then 6/20/12 full rash/hives back of head. Joint pain very sleepy, flu like lasting until 6/20/12, then flu like until 6/22/12 and very sleepy.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Rash, Somnolence, Urticaria
Clinical narrative: Diarrhea, joint pain, sleepy, flu like, low grade fever on 6/19/12 then 6/19 6:00pm or so, hives/rash begining at nap, then 6/20/12 full rash/hives back of head. Joint pain very sleepy, flu like lasting until 6/20/12, then flu like until 6/22/12 and very sleepy.
Age: 61.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Local reaction
Clinical narrative: Localized reaction only. Reporting requested by provider.
Age: 3.0
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: No patient adverse event.  The wrong diluant was used with the vaccine.
Sex: F
Vaccine: FLU3
Symptoms: Maternal exposure during pregnancy, Renal failure
Clinical narrative: Case number PHHY2012US051995 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination, she had kidney failure. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after administration of INFLUENZA vaccine.